Showing results (2251-2260 of 2,459) with videos related to
Sort By:
Pageof 246
Therapie|April 11, 2015
Evaluation of abuse and dependence in addiction monitoring systems: tramadol as an exampleAnne Roussin, Odile Doazan-d'Ouince, Hélène Géniaux, et al.Therapie|March 10, 2015
What strategy should France implement for H2020?Jean-François Dhainaut, Vincent Diebolt, Brigitte Pouletty-Lefèbvre, et al.Therapie|August 24, 2020
[Analysis of regulatory status changes of drugs in France: 2010-2019]Marie Castanié, Blandine Juillard-Condat, Christian Galian, et al.Therapie|July 11, 2020
[Drug interactions with colchicine, are the contraindications well respected? A descriptive study of prescriptions in Brittany based on data from the French National Health Data System]Marion Girard de Courtilles, Frédéric Balusson, Claudine Queric, et al.Therapie|July 13, 2020
[Summary of the recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on the therapeutic drug monitoring of tacrolimus]Florian Lemaitre, Caroline Monchaud, Jean-Baptiste Woillard, et al.Therapie|July 16, 2020
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A reviewLucile Grange, Philippe Guilpain, Marie-Elise Truchetet, et al.Therapie|July 27, 2020
Evolution of clotting factor concentrates prescriptions and impact of recommendations of prophylaxis in children with haemophiliaFlorianne Bel, Sandrine Meunier, Anne Lienhart, et al.Therapie|April 3, 2023
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, et al.Therapie|April 10, 2021
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance studyMarie Bastin, Marion Allouchery, Marion Sassier, et al.Pageof 246